Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥849.81 million, a decrease of 3.16% compared to ¥877.55 million in the same period last year[17]. - The net profit attributable to shareholders for the first half of 2021 was approximately ¥82.86 million, down 48.52% from ¥160.96 million in the previous year[17]. - The basic earnings per share for the first half of 2021 was ¥0.52, a decline of 62.59% compared to ¥1.39 in the same period last year[19]. - The net cash flow from operating activities was negative at approximately -¥142.55 million, a decrease of 223.66% compared to ¥115.27 million in the previous year[18]. - The total operating revenue for the first half of 2021 was ¥849,812,969.21, a decrease of 3.16% compared to ¥877,548,279.67 in the previous year[47]. - Operating costs increased by 11.94% to CNY 661,643,505.85 from CNY 591,073,814.69 in the previous year[47]. - The company's cash and cash equivalents decreased by 56.55% to CNY 279,890,204.53 from CNY 644,221,917.06 in the previous year[47]. - The company's net profit for the first half of 2021 was CNY 77,061,128.47, a decrease from CNY 162,515,150.93 in the same period of 2020, representing a decline of approximately 52.6%[155]. Assets and Liabilities - The total assets at the end of the reporting period were approximately ¥2.01 billion, an increase of 0.50% from ¥1.99 billion at the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were approximately ¥1.37 billion, an increase of 2.09% from ¥1.34 billion at the end of the previous year[18]. - The total assets at the end of the reporting period amounted to 162,676,080.00 RMB, indicating growth in the company's asset base[186]. - Total liabilities decreased to ¥639,801,859.78 from ¥657,958,158.11, a decline of about 2.4%[144]. - Current liabilities decreased to ¥595,097,882.33 from ¥622,705,373.57, a reduction of about 4.4%[144]. - Non-current liabilities increased to ¥44,703,977.45 from ¥35,252,784.54, representing a rise of approximately 27%[144]. Research and Development - The company has established a comprehensive R&D system, with ongoing investments in technology innovation, leading to a competitive edge in the agricultural pesticide sector[34]. - Research and development expenses rose by 15.53% to CNY 22,047,351.79 from CNY 19,083,730.87 in the previous year[47]. - The company plans to increase R&D investment to achieve product differentiation and enhance its comprehensive competitiveness in the pesticide industry[61]. - The company is investing heavily in R&D, with a budget increase of 30% to enhance technology development and innovation[93]. Market Strategy and Competition - The company focuses on the research, production, and sales of environmentally friendly pesticides, with a core business in herbicides supplemented by insecticides and fungicides[25]. - The sales strategy combines direct sales and distribution, allowing the company to quickly respond to market demands and reduce costs[28]. - The global pesticide market has seen a slowdown, maintaining an annual growth rate of around 4% since 2015, with demand driven by agricultural profitability and environmental regulations[29]. - The pesticide industry is undergoing consolidation, with major global players engaging in mergers and acquisitions to strengthen their market positions[30]. - The company aims to expand its market share by optimizing resource allocation and continuously developing new products[28]. Environmental and Safety Compliance - The company has maintained a strong focus on safety production, adhering to national safety regulations and achieving zero major safety incidents during the reporting period[32]. - The company has invested over 90% of hazardous waste for self-disposal, ensuring efficient treatment and compliance with environmental standards[33]. - The company emphasizes strict compliance with safety and environmental regulations to avoid production halts or penalties, ensuring stable operations[60]. - The company has received multiple safety and environmental management certifications, including ISO14001:2015 and ISO45001:2018, ensuring compliance with quality management standards[39]. Shareholder and Governance - The company did not distribute profits or increase capital reserves during the reporting period[4]. - The company has established a lock-up period for shareholders, limiting share transfers to 25% of their holdings annually for a period of two years post-lock-up[99]. - The company’s board members and senior management are required to report their shareholdings and any changes during their tenure[99]. - The company reported a reduction in shareholding by Jiangsu Gaotou Ningtai, which amounted to 1,230,400 shares, representing a 1.06% decrease in total shares held[103]. Future Outlook - The company provided an optimistic outlook for the second half of 2021, projecting a revenue growth of 25%[95]. - New product launches are expected to contribute an additional 300 million in revenue by the end of the year[96]. - The company plans to enhance service frequency to end-users and introduce new product development and sales talent[44]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[182].

Financial Performance - Net profit attributable to shareholders decreased by 40.12% to CNY 50,375,579.42 year-on-year[8] - Total profit decreased by 39.02% to CNY 60,009,839.28, mainly due to a decline in sales gross margin[13] - Basic earnings per share dropped by 57.43% to CNY 0.43[8] - Net profit for Q1 2021 was CNY 50,375,579.42, a decrease of 40.19% compared to CNY 84,120,583.20 in Q1 2020[28] - Operating profit for Q1 2021 was ¥64.36 million, down 37.47% from ¥102.87 million in Q1 2020[31] - Net profit for Q1 2021 was ¥54.32 million, a decline of 37.00% compared to ¥86.25 million in Q1 2020[31] Revenue and Costs - Operating revenue increased slightly by 0.82% to CNY 454,318,728.70 compared to the same period last year[8] - Total operating revenue for Q1 2021 was CNY 454,318,728.70, a slight increase of 0.15% compared to CNY 450,623,121.84 in Q1 2020[27] - Total operating costs increased to CNY 391,714,150.25, up 13.14% from CNY 346,177,246.22 in the same period last year[27] - The company's operating revenue for Q1 2021 was ¥383.30 million, a decrease of 2.37% compared to ¥393.23 million in Q1 2020[30] Cash Flow and Liquidity - Cash flow from operating activities showed a significant decline of 165.98%, resulting in a net outflow of CNY 47,489,648.54[8] - The cash flow from operating activities showed a net outflow of CNY 47,489,648.54, a decrease of 165.98% compared to the previous year[15] - Cash flow from operating activities reflects the company's ability to generate cash from its core business operations[39] - The company maintained a healthy cash position, which is crucial for future investments and operational stability[39] - The company reported a significant increase in cash and cash equivalents, indicating strong liquidity management[39] Assets and Liabilities - Total assets increased by 4.02% to CNY 2,077,228,615.85 compared to the end of the previous year[8] - The total current liabilities decreased by 32.24% to CNY 35,692,550.68, primarily due to a reduction in advance payments from customers[14] - The accounts payable decreased to CNY 160,780,022.09, down from CNY 167,712,860.43, indicating improved cash management[19] - Total liabilities increased to CNY 606,451,824.02, up 3.41% from CNY 586,582,585.19[23] Shareholder Information - The number of shareholders reached 12,056 at the end of the reporting period[10] Tax and Refunds - The company received tax refunds amounting to CNY 13,054,941.72, representing a 251.15% increase year-on-year due to increased export tax rebates[14] - The company received ¥13.05 million in tax refunds during Q1 2021, compared to ¥3.72 million in Q1 2020, showing improved cash flow management[35] Research and Development - The company reported a significant increase in research and development expenses to CNY 10,130,613.97, up from CNY 9,284,010.12, reflecting a focus on innovation[27] - Research and development expenses increased to ¥10.08 million in Q1 2021, compared to ¥9.31 million in Q1 2020, reflecting a focus on innovation[30] Other Financial Metrics - The weighted average return on net assets decreased by 3.66 percentage points to 3.69%[8] - Sales expenses decreased by 38.41% to CNY 9,481,025.26, attributed to the reclassification of shipping and export fees[13] - The company reported a significant increase in other current liabilities, which rose by 70.72% to CNY 86,641,854.16, attributed to increased provisions for sales of formulation products[14] - The deferred income tax liabilities increased by 70.42% to CNY 2,161,944.95, primarily due to an increase in estimated return costs for new formulation sales[14] Cash Management - The cash paid for purchasing goods and services was CNY 195,214,883.51, a 79.56% increase compared to the previous year, mainly due to the payment of matured bank drafts[15] - The company’s cash and cash equivalents decreased to CNY 415,694,343.10 from CNY 644,221,917.06, indicating a liquidity contraction[17] Financial Reporting - The financial report did not include any audit report, indicating that the financials were not subject to external audit scrutiny[40] - The company did not apply the new lease accounting standards for the first quarter of 2021[40]

Financial Performance - The company's operating revenue for 2020 was approximately ¥1.49 billion, representing a year-on-year increase of 72.58% compared to ¥865.76 million in 2019[21]. - Net profit attributable to shareholders reached approximately ¥235.68 million, a significant increase of 578.05% from ¥34.76 million in 2019[21]. - Basic earnings per share rose to ¥2.10, up 388.37% from ¥0.43 in 2019[22]. - The weighted average return on equity increased to 19.42%, up 16.27 percentage points from 3.15% in 2019[22]. - The total assets of the company at the end of 2020 were approximately ¥1.997 billion, reflecting a 29.77% increase from ¥1.539 billion at the end of 2019[21]. - The company reported a significant increase in cash and cash equivalents by CNY 267.62 million, mainly due to the redemption of financial products[35]. - The company reported a total revenue of RMB 149,167.88 million, representing a year-on-year increase of 72.36%[104]. - Domestic sales accounted for RMB 100,649.93 million, with a growth of 51.12%, while export sales surged by 143.30% to RMB 48,517.96 million[104]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of RMB 5.00 per 10 shares, totaling RMB 58,116,800.00, which represents 24.66% of the net profit attributable to shareholders[5]. - The profit distribution policy prioritizes cash dividends, with a minimum distribution of 10% of the available profit for the year, and cumulative distributions over three years should not be less than 30% of the average annual distributable profit[142]. - The company has maintained a stable dividend payout ratio, with a focus on balancing shareholder returns and reinvestment for growth[150]. - The total cash dividends distributed over the last three years amounted to RMB 11,057.54 million, reflecting a consistent return to shareholders[150]. - The company’s cash dividend policy has been executed transparently, with detailed announcements made prior to implementation[147]. Operational Developments - The company completed the construction and installation of new production lines for several products, including 1,000 tons of Triclopyr and 700 tons of Cyhalofop-butyl, which are now entering trial production[30]. - A new formulation division was established to enhance the market influence of the company's products, separating production, procurement, and sales from the previous unified management model[30]. - The company has formed a sales model combining direct sales and distribution, with direct sales primarily for raw materials, enhancing brand influence and market responsiveness[33]. - The company has developed a robust marketing network across multiple cities in China and established stable sales channels in international markets, enhancing sales scale and risk resilience[42]. Research and Development - The company has established a comprehensive R&D system, supported by various research platforms, and continues to invest in technology innovation[40]. - Research and development expenses increased by 10.02% to 47.7 million yuan, reflecting the company's commitment to innovation[53]. - The company has filed 2 new patent applications during the reporting period, enhancing its innovation capabilities[89]. - The company has been actively pursuing technological innovation, achieving significant improvements in production processes that enhance safety and reduce costs[89]. Environmental and Compliance - The company emphasizes environmental protection, achieving over 90% self-disposal of hazardous waste and maintaining compliance with environmental standards[38]. - The construction of the Sichuan Guang'an base project will enhance the company's investment in environmental protection and ensure sustainable development[38]. - The implementation of the new Solid Waste Law is expected to enhance environmental compliance and reshape market competition in the chemical industry[74]. - The company has received multiple safety and environmental certifications, ensuring compliance and enhancing operational stability[43]. Financial Management - The company has successfully completed multiple financial products with returns ranging from 2.80% to 7.00%[192]. - The company is actively managing a diverse portfolio of financial products with varying risk profiles and returns[192]. - The company has reported a successful track record of achieving expected returns across multiple financial products[192]. - The company has engaged in various asset management plans, with expected returns between 5.8% and 6.5%[192]. Strategic Goals and Future Plans - The company aims to enter the top 20 in China's agricultural chemical industry by 2025, focusing on original drug and formulation business growth[119]. - The company plans to enhance production management and expand production scale while reducing costs through automation and process upgrades[120]. - The company is committed to sustainable development, emphasizing safety and environmental protection as foundational principles[122]. - The company will continue to invest in research and development to achieve product differentiation and enhance competitiveness in the agricultural chemicals market[129]. Risk Management - The company has outlined potential risks in its future development plans, which investors should be aware of[8]. - The company faces risks related to regulatory policy changes, which could impact production and operational costs[127]. - The company is addressing the risk of raw material price fluctuations by closely monitoring market changes and optimizing procurement strategies[130].

Financial Performance - Net profit attributable to shareholders increased by 277.90% to CNY 180,433,891.27 for the first nine months of the year[7] - Operating revenue for the first nine months reached CNY 1,100,125,601.15, a 50.82% increase year-on-year[7] - The net cash flow from operating activities surged by 297.00% to CNY 130,439,977.67 compared to the same period last year[7] - Basic earnings per share rose by 150.00% to CNY 1.50[8] - Diluted earnings per share increased by 153.33% to CNY 1.52[8] - The weighted average return on equity improved by 10.90 percentage points to 15.19%[8] - Total operating revenue for Q3 2020 reached ¥222,577,321.48, a significant increase from ¥66,850,454.74 in Q3 2019, representing a growth of approximately 233%[33] - The company's net profit for the first three quarters of 2020 was ¥464,701,348.56, compared to ¥296,881,022.24 in the same period of 2019, indicating an increase of around 56%[30] - The net profit for Q3 2020 was ¥19,477,594.55, compared to a net loss of ¥35,167,166.61 in Q3 2019, indicating a turnaround in profitability[36] - The total profit for Q3 2020 reached ¥22,443,505.37, contrasting with a loss of ¥42,108,230.30 in the same period last year[35] Assets and Liabilities - Total assets increased by 23.52% to CNY 1,900,822,532.41 compared to the end of the previous year[7] - The company's cash and cash equivalents increased by 40.51% to ¥529,181,476.23 due to higher sales revenue and increased bank deposits[13] - Accounts receivable rose significantly by 372.00% to ¥180,644,971.07, attributed to increased sales and extended credit terms[13] - The total liabilities increased significantly, with accounts payable rising by 225.37% to ¥249,920,988.62, indicating increased supplier payments[14] - The company’s total liabilities increased to RMB 620.09 million as of September 30, 2020, compared to RMB 436.93 million at the end of 2019, reflecting a growth of 42%[26] - The company's total assets as of Q3 2020 amounted to ¥1,775,688,454.71, compared to ¥1,462,154,225.92 in Q3 2019, marking an increase of about 21.5%[30] - Total liabilities increased to ¥522,036,636.67 in Q3 2020 from ¥385,150,170.95 in Q3 2019, representing a growth of approximately 35.6%[30] Cash Flow - Cash flow from operating activities showed a net increase of 297.00% to ¥130,439,977.67, driven by higher sales and improved cash collection[16] - Cash inflow from operating activities totaled CNY 791,512,069.17 for the first nine months of 2020, up from CNY 607,335,009.95 in 2019, reflecting an increase of about 30.2%[44] - The cash flow from operating activities for the first nine months of 2020 was CNY 130,439,977.67, a substantial increase from CNY 32,856,817.25 in the same period last year[43] - The cash flow from investing activities showed a net outflow of CNY 18,139,128.42 in the first nine months of 2020, an improvement from a net outflow of CNY 117,691,472.27 in the same period last year[43] - The net cash flow from investment activities was negative CNY 52,480,459.74 for the first three quarters of 2020, an improvement from negative CNY 116,160,893.09 in 2019[44] Shareholder Information - The total number of shareholders reached 9,560 by the end of the reporting period[10] - The top shareholder, Yin Fengshan, holds 41.65% of the shares, totaling 48,375,341 shares[10] Investment and Projects - The company established a wholly-owned subsidiary, Sichuan Fengshan Biotechnology Co., Ltd., with a registered capital of RMB 100 million[18] - The total investment for the pesticide and fine chemical products project in Guang'an, Sichuan is approximately RMB 160 million[18] - The company announced a change in fundraising projects, replacing the original project for a production line with an annual capacity of 1,500 tons of nitro-sulfonyl ketone with a new project for 1,600 tons of 2-nitro-4-methylsulfonyl benzoic acid and 750 tons of cyclohexanone, with a total investment of RMB 145.88 million[21] Research and Development - Research and development expenses for Q3 2020 were ¥14,494,715.95, compared to ¥11,095,432.14 in Q3 2019, showing an increase of about 30%[33] - Research and development expenses for Q3 2020 amounted to ¥14,678,594.43, an increase from ¥11,645,991.93 in Q3 2019, reflecting a focus on innovation[37] Challenges and Outlook - The company experienced delays in several fundraising projects due to external factors, including maintenance of the steam pipeline and the impact of the COVID-19 pandemic[20] - The company is expected to face significant fluctuations in cumulative net profit compared to the previous year due to operational disruptions in 2019 and early 2020[22] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[34]

Financial Performance - The company's operating revenue for the first half of 2020 reached ¥877,548,279.67, representing a 32.45% increase compared to ¥662,564,246.72 in the same period last year[19]. - Net profit attributable to shareholders increased by 94.12% to ¥160,956,296.72 from ¥82,914,231.01 year-on-year[19]. - The net cash flow from operating activities surged by 163.55% to ¥115,270,701.20, compared to ¥43,738,061.04 in the previous year[19]. - Basic earnings per share rose to ¥1.94, an increase of 86.54% compared to ¥1.04 in the same period last year[20]. - The weighted average return on equity increased by 6.37 percentage points to 13.63% from 7.26% year-on-year[20]. - The company achieved operating revenue of 878 million RMB, a year-on-year increase of 32.45%[45]. - The net profit attributable to shareholders reached 161 million RMB, up 94.12% year-on-year[45]. - The net profit excluding non-recurring gains and losses was 156 million RMB, reflecting a 106.60% increase compared to the previous year[45]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan for the first half of 2020, representing a 20% year-over-year growth[72]. Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥2,017,667,119.74, a 31.12% increase from ¥1,538,852,674.82 at the end of the previous year[19]. - The total liabilities as of June 30, 2020, were ¥759,351,113.11, compared to ¥436,929,280.39 at the end of 2019, indicating an increase of about 74%[118]. - The total current assets reached ¥1,458,986,763.67 as of June 30, 2020, up from ¥1,002,335,625.42 at the end of 2019, reflecting a growth of approximately 46%[117]. - The company's total equity attributable to shareholders was ¥1,258,316,006.63 as of June 30, 2020, compared to ¥1,101,923,394.43 at the end of 2019, indicating an increase of about 14%[118]. - The company's accounts receivable increased to ¥293,329,059.41 as of June 30, 2020, from ¥38,272,482.31 at the end of 2019, showing a significant rise of approximately 667%[116]. Cash Flow - The company's cash and cash equivalents increased by 65.75% compared to the beginning of the year, primarily due to increased sales and improved collection of receivables[32]. - Cash flow from operating activities increased by 163.55% to 115 million RMB, driven by higher sales and improved cash collection[48]. - Cash and cash equivalents at the end of the period totaled ¥424,591,812.73, a significant increase from ¥117,612,106.63 at the end of the same period last year[136]. - The net increase in cash and cash equivalents for the period was ¥116,110,283.94, contrasting with a decrease of ¥136,441,839.42 in the same period last year[136]. Market Strategy and Operations - The company is engaged in the research, production, and sales of environmentally friendly pesticides, with a focus on four main active ingredients[26]. - The company has established a dual sales model combining direct sales and distribution, enhancing market penetration and brand influence[28]. - The company aims to expand its product range and market share through continuous research and development of new products[29]. - The company has formed a collaborative sales structure between domestic and international markets to mitigate seasonal fluctuations in pesticide sales[29]. - The company plans to leverage opportunities from the consolidation in the agricultural chemical industry due to the pandemic, aiming to expand its market share[49]. Research and Development - The company has established several R&D platforms, including a technology center and an academic workstation, to enhance its technical innovation capabilities and product development[35]. - The company continues to strengthen its R&D capabilities by attracting high-end talent and upgrading equipment, aiming to develop new pesticide formulations[42]. - The company plans to expand its product line from herbicides to include fungicides, insecticides, and acaricides, supported by advanced testing equipment and laboratories[35]. Environmental Management - The company has invested in environmental protection facilities during the production halt in 2019, becoming the first enterprise in Yancheng to resume production, ensuring compliance with national and local environmental standards[33]. - The company has implemented a comprehensive environmental management system, including regulations for wastewater and waste gas management[90]. - The company has established an online monitoring system for waste gas emissions, ensuring compliance with environmental regulations[89]. - The company has maintained a stable operation of its environmental protection facilities, effectively reducing the discharge of pollutants[90]. Shareholder Information - The total number of shares decreased from 83,005,000 to 82,965,000, a reduction of 40,000 shares due to the repurchase of restricted stock[101]. - The largest shareholder, Yin Fengshan, holds 34,553,815 shares, representing 41.65% of the total shares[107]. - The company has no preferred shareholders with restored voting rights as of the reporting date[105]. - The total number of shareholders reached 8,286 by the end of the reporting period[105]. Risk Management - The company has outlined potential risks in the report, which investors should be aware of[5]. - The company faces risks of product substitution due to evolving pest resistance and the demand for more efficient pesticide formulations, which could impact market share and brand recognition[66]. - The company will continuously monitor the agricultural chemical market environment and adjust project plans based on market changes and uncertainties[65]. Corporate Governance - The company did not distribute profits or increase capital reserves during the reporting period[4]. - All resolutions from the 2019 annual general meeting were approved, reflecting shareholder support for the company's strategic direction[69]. - The company’s actual controllers have committed not to transfer or manage their shares for a period of 16 months post-IPO, ensuring stability in shareholding[71].

Financial Performance - Net profit attributable to shareholders increased by 57.99% to CNY 84,120,583.20 year-on-year[6] - Operating revenue rose by 23.75% to CNY 450,623,121.84 compared to the same period last year[6] - Net profit for the first quarter was ¥84,120,583.20, representing a 57.99% increase year-on-year, attributed to higher sales and gross margin growth[15] - Total operating revenue for Q1 2020 was CNY 450,623,121.84, an increase of 23.8% compared to CNY 364,131,974.88 in Q1 2019[29] - The total profit for Q1 2020 was CNY 98,403,359.42, up from CNY 63,751,976.73 in Q1 2019, representing a 54.5% increase[30] Earnings and Shareholder Metrics - Basic earnings per share increased by 32.89% to CNY 1.01[6] - Basic earnings per share increased by 32.89% to ¥1.01, reflecting significant growth in net profit[15] - The number of shareholders reached 7,889 at the end of the reporting period[11] - The top shareholder, Yin Fengshan, holds 41.63% of the shares, totaling 34,553,815 shares[11] Cash Flow and Liquidity - Net cash flow from operating activities surged by 287.42% to CNY 71,976,060.65 year-on-year[6] - Cash flow from operating activities increased by 287.42% to ¥71,976,060.65, driven by cash settlements from sales and increased bank draft payments to suppliers[17] - The total cash inflow from operating activities was ¥300,445,915.07, compared to ¥279,013,197.09 in the same period last year, indicating an increase of about 7.5%[36] - The company reported a net increase in cash and cash equivalents of ¥67,281,920.83, compared to a net increase of ¥2,721,114.74 in the previous year[37] Assets and Liabilities - Total assets increased by 19.27% to CNY 1,835,458,479.14 compared to the end of the previous year[6] - Total liabilities reached CNY 646,444,801.51, compared to CNY 436,929,280.39, which is an increase of approximately 48.0%[23] - Current assets totaled CNY 1,292,718,994.28, up from CNY 1,002,335,625.42, indicating a growth of about 29.0%[21] - Total liabilities as of Q1 2020 amounted to CNY 534,900,507.87, compared to CNY 385,150,170.95 in Q1 2019, a rise of 38.8%[30] Investments and Non-Recurring Gains - The company reported a non-recurring gain of CNY 1,733,214.72 for the period[9] - The company reported an investment income of CNY 4,705,238.20 in Q1 2020, compared to CNY 2,697,983.16 in Q1 2019, a significant increase of 74.1%[30] - Investment cash inflow decreased by 57.06% to ¥173,344,779.34, primarily due to reduced redemptions of bank wealth management products[17] Other Financial Metrics - The weighted average return on equity increased by 2.66 percentage points to 7.35%[6] - Research and development expenses for Q1 2020 were CNY 9,284,010.12, up from CNY 7,572,325.80 in Q1 2019, marking a 22.7% increase[30] - The company experienced a decrease in financial expenses, reporting a net financial income of CNY -2,183,578.17 in Q1 2020 compared to CNY 1,218,276.28 in Q1 2019[30]

Dividend Distribution - The company plans to distribute a cash dividend of RMB 1.26 per 10 shares, totaling RMB 10,458,630, which accounts for 30.09% of the net profit attributable to ordinary shareholders[4]. - The company plans to distribute cash dividends of 5.25 RMB per 10 shares for the year 2018, totaling 42 million RMB, with a distribution rate of 30.09% of the net profit attributable to ordinary shareholders[157]. - For the year 2019, the proposed cash dividend is 1.26 RMB per 10 shares, along with a capital reserve increase of 4 shares per 10 shares, maintaining the distribution ratio[158]. - The company’s cash dividend policy stipulates that at least 10% of the distributable profit must be distributed as cash dividends annually, with a cumulative distribution of at least 30% over any three consecutive years[153]. - The company’s cash flow must be sufficient to support dividend payments without affecting its ongoing operations[153]. - The company’s board of directors must consider industry characteristics, development stage, and major capital expenditure plans when proposing dividend policies[154]. - The company has committed to providing transparent disclosures regarding its profit distribution policies and any adjustments made[157]. - The company’s profit distribution policy adjustments require approval from two-thirds of the voting rights at the shareholders' meeting[155]. - The company has not proposed a cash profit distribution plan for the reporting period despite having positive distributable profits, which requires detailed disclosure of reasons and future plans[161]. - The company committed to strictly follow the profit distribution policy as outlined in the draft articles of association, including cash dividend policies[166]. Financial Performance - The company's operating revenue for 2019 was ¥865,755,070.17, a decrease of 34.24% compared to ¥1,316,552,081.21 in 2018[21]. - The net profit attributable to shareholders for 2019 was ¥34,758,894.90, down 74.96% from ¥138,785,929.78 in 2018[21]. - Basic earnings per share for 2019 were ¥0.43, a decline of 79.91% from ¥2.14 in 2018[22]. - The total assets at the end of 2019 were ¥1,538,852,674.82, an increase of 3.19% from ¥1,491,259,917.31 at the end of 2018[21]. - The company reported a significant reduction in costs, with total operating costs down by 35.36% to 621,817,306.02[64]. - The company achieved a sales revenue of 866 million RMB in 2019, a decrease of 34.24% compared to 1.317 billion RMB in the previous year[54]. - The net profit for 2019 was 35 million RMB, down 74.96% from 139 million RMB in 2018[46]. - The company’s cash flow from operating activities was 122 million RMB, a decrease of 19.95% from 153 million RMB in the previous year[54]. Operational Challenges - The company faced production halts from April to October 2019 due to external factors, impacting its operational capacity[32]. - The company experienced a temporary shutdown of its original drug synthesis workshop from April 18, 2019, to October 25, 2019, due to safety inspections and upgrades[105]. - The company adjusted its sales strategy during the production halt, focusing on the production and sale of formulations instead of raw materials[32]. - The company faced a production halt from April 18, 2019, to October 25, 2019, lasting over 6 months due to safety inspections, which may lead to customer attrition[142]. Risk Management - The company has outlined potential risks in its future development discussions, which investors should be aware of[7]. - The company recognizes the risk of regulatory changes in safety and environmental policies, which could impact operational costs and performance if compliance is not met[140]. - The company is exposed to exchange rate risks due to international exports and will strengthen research on international trade and currency policies to mitigate these risks[143]. Research and Development - Research and development expenses increased by 4.53% to 43 million RMB, reflecting the company's commitment to innovation despite overall revenue decline[57]. - The company completed three new patent applications during the reporting period, indicating ongoing investment in R&D[49]. - The company is focusing on enhancing its R&D capabilities, having submitted three new patent applications during the reporting period[97]. Market Strategy - The company’s sales model combines direct sales and distribution, allowing for quick adaptation to market changes and enhancing brand influence[35]. - The company has established a comprehensive marketing network across various cities in China and has stable sales channels in regions like Oceania and South America[42]. - The company is focusing on expanding its product structure and diversifying its product offerings to better manage quality and meet market demands[87]. - The company is actively expanding its sales network through its subsidiary Fengshan Agricultural Chemicals, establishing branches across multiple regions in China[94]. Compliance and Governance - The company has received a standard unqualified audit report from the accounting firm, ensuring the accuracy and completeness of the financial report[4]. - The company’s financial report has been guaranteed by the board of directors, supervisors, and senior management for its authenticity and completeness[8]. - The company is subject to various regulatory requirements as outlined in the relevant laws and regulations[12]. - There are no non-operating fund occupations by controlling shareholders or related parties reported[7]. - The company has not violated any decision-making procedures regarding external guarantees[7]. Environmental and Safety Investments - The company has invested significantly in safety and environmental upgrades, enhancing its operational safety and compliance with new regulations[38]. - The company prioritizes safety and environmental compliance, leading to significant investments in upgrading facilities and processes[47]. - The implementation of the Soil Pollution Prevention and Control Law has led to stricter regulations for key industries, including petrochemical and chemical sectors, with a focus on pollution permits and waste management[81]. Financial Management - The company has engaged in wealth management with a total of 234,000,000.00 RMB from raised funds and 130,000,000.00 RMB from self-owned funds[184]. - The company has successfully recovered all invested amounts from its wealth management products, demonstrating effective financial management[186]. - The expected returns across various products range from 1.8% to 5.0%, indicating a diversified investment strategy aimed at maximizing returns[188].

Financial Performance - Operating revenue for the first nine months was CNY 729,414,701.46, a decrease of 27.84% year-on-year[7] - Net profit attributable to shareholders decreased by 49.73% to CNY 47,747,064.40 for the first nine months[8] - Basic earnings per share dropped by 62.30% to CNY 0.5968[8] - The weighted average return on net assets decreased by 12.21 percentage points to 4.29%[8] - The company reported a net loss of ¥36,604,354.43 for Q3 2019, compared to a profit of ¥6,520,475.42 in the same period last year[43] - Net profit attributable to the parent company for Q3 2019 was -35,167,166.61 RMB, compared to a profit of 9,395,826.12 RMB in Q3 2018, indicating a significant decline[39] - The company anticipates a potential decline of 50% in net profit attributable to shareholders for the year compared to the previous year due to the prolonged shutdown of the workshop[24] Cash Flow - Net cash flow from operating activities decreased by 59.21% to CNY 32,856,817.25 compared to the same period last year[7] - Cash inflow from operating activities totaled ¥697,040,369.43, down 18.1% from ¥851,878,366.24 in the previous year[47] - The company reported a net increase in cash and cash equivalents of -¥146,132,928.32, contrasting with an increase of ¥437,529,562.59 in the previous year[52] - The net cash flow from operating activities decreased to ¥15,998,429.85 in the first three quarters of 2019, down 76.3% from ¥67,353,038.63 in the same period of 2018[50] Assets and Liabilities - Total assets decreased by 8.72% to CNY 1,361,180,005.10 compared to the end of the previous year[7] - The company's cash and cash equivalents decreased by 41.28% to ¥207,734,014.79 compared to the end of the previous year, primarily due to idle funds being used for purchasing financial products[13] - Total liabilities decreased, with accounts payable down by 39.00% to ¥73,662,112.69, mainly due to reduced raw material procurement[14] - The total liabilities as of Q3 2019 amounted to ¥174,950,257.61, down from ¥355,882,161.83 in the previous year, a reduction of approximately 50.9%[34] - The company's total liabilities decreased to CNY 248,248,241.17 from CNY 382,576,714.42, a reduction of approximately 35%[29] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,134[10] - The largest shareholder, Yin Fengshan, holds 43.19% of the shares[10] - The company distributed dividends amounting to CNY 42,040,838.49, an increase of 30.04% compared to the same period last year[17] Operational Changes - The raw material synthesis workshop was temporarily shut down on April 18, 2019, due to the cessation of heating supply, significantly impacting production and sales[18] - The company plans to apply for the removal of "other risk warnings" once the raw material synthesis workshop operates stably after resuming production on October 25, 2019[19] Government Support and Other Income - Government subsidies recognized in the current period amounted to CNY 3,314,747.43[9] - The company reported a 56.11% increase in other income to ¥3,019,549.11, primarily from increased non-operating government subsidies[15] Investment and Construction - The company's construction in progress increased by 277.79% to ¥61,840,384.22, reflecting investments in safety and environmental upgrades[14] - Investment income increased significantly by 1,759.65% to ¥10,619,352.36, primarily from the purchase of financial products with idle funds[15] Research and Development - Research and development expenses for the first three quarters of 2019 were ¥30,708,692.60, compared to ¥33,820,397.36 in the same period of 2018, showing a decrease of approximately 9.3%[36] - Research and development expenses for Q3 2019 were 11,645,991.93 RMB, slightly up from 10,832,743.29 RMB in Q3 2018, showing a focus on innovation despite financial losses[42]

Financial Performance - The company's operating revenue for the first half of 2019 was ¥662,564,246.72, a decrease of 17.38% compared to ¥801,948,626.85 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was ¥82,914,231.01, down 3.11% from ¥85,576,688.03 in the previous year[19]. - The net profit after deducting non-recurring gains and losses was ¥75,782,683.06, a decrease of 7.88% compared to ¥82,262,069.90 in the same period last year[19]. - The net cash flow from operating activities was ¥43,738,061.04, down 15.95% from ¥52,040,167.36 in the previous year[19]. - Basic earnings per share decreased by 27.27% to CNY 1.04 compared to CNY 1.43 in the same period last year[20]. - The company's net profit excluding non-recurring gains and losses fell by 30.66% to CNY 0.95 per share, primarily due to a 17.38% decline in sales revenue[20]. - The weighted average return on equity decreased by 7.61 percentage points to 7.26% from 14.87% year-on-year[20]. - The company experienced a production halt in the second quarter, leading to a decrease in output and a net profit decline of 7.88%[20]. - Net profit for the first half of 2019 was CNY 0.76 billion, a year-on-year decrease of 7.88%[44]. - Earnings per share (EPS) decreased by 27.27% to CNY 1.04, with a non-GAAP EPS of CNY 0.95[44]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,544,941,784.93, an increase of 3.60% from ¥1,491,259,917.31 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company at the end of the reporting period were ¥1,148,098,930.54, an increase of 3.56% from ¥1,108,683,202.89 at the end of the previous year[19]. - Accounts receivable increased by 153 million yuan compared to the beginning of the year, mainly due to a significant amount of sales payments pending collection[33]. - Inventory decreased by 123 million yuan compared to the beginning of the year, primarily due to production declines and sales consuming most of the inventory[33]. - Total liabilities rose to CNY 396,842,854.39 from CNY 382,576,714.42, indicating an increase of approximately 3.3%[115]. - The company's equity attributable to shareholders increased to CNY 1,148,098,930.54 from CNY 1,108,683,202.89, reflecting a growth of about 3.6%[115]. Environmental and Operational Initiatives - The company invested 44 million yuan in environmental protection during the reporting period, enhancing its overall environmental production level[34]. - The company has a production capacity of 20,000 tons for pesticide formulations and 20,000 tons for four major active ingredients, which helps mitigate cyclical risks[36]. - The company has established a complete quality control system and has received multiple quality management certifications, ensuring compliance with industry standards[38]. - The company has built a stable sales network in major pesticide usage areas, enhancing its market presence both domestically and internationally[40]. - The company has implemented a "source control, facility upgrade, and emission reduction" strategy for waste management, continuously increasing investment in environmental protection technologies[87]. - The company has a wastewater online monitoring system that has been operational since 2008, monitoring COD, pH, ammonia nitrogen, total nitrogen, and total phosphorus, and is functioning normally[86]. - The company has not faced any environmental penalties or pollution incidents during the reporting period[93]. Risks and Challenges - The company has detailed potential risks in the report, which can be found in the section discussing operational conditions[6]. - The report includes a forward-looking statement risk declaration, indicating that future plans do not constitute a substantive commitment to investors[5]. - The company faces risks from regulatory policy changes, particularly in the chemical industry, which could lead to production limitations or penalties if compliance is not met[60]. - The company is at risk of customer attrition due to production disruptions caused by external factors, such as the temporary shutdown of its raw material synthesis workshop[61]. - The company is exposed to exchange rate risks due to its export activities, which may impact its financial performance[62]. Shareholder and Governance Information - The company held its 2018 annual shareholders' meeting on May 17, 2019, where all proposed resolutions were approved[69]. - The proposed profit distribution plan includes a stock dividend of 10 shares for every 10 shares held, with no cash dividends or capital reserve fund transfers planned[70]. - The actual controller and major shareholders have committed not to transfer or entrust the management of their shares for 36 months from the date of the company's IPO, ensuring stability in shareholding[72]. - The company will strictly adhere to its profit distribution policy as outlined in its articles of association, including cash dividend policies[73]. - The company has committed to implementing profit distribution decisions as per the resolutions passed in relevant shareholder meetings[73]. Financial Reporting and Accounting Policies - The financial statements are prepared based on the going concern principle, with no significant factors affecting the company's ability to continue operations identified for the next 12 months[150]. - The company adheres to the relevant accounting standards, ensuring that financial reports accurately reflect its financial position and operating results[152]. - The company uses RMB as its accounting currency, ensuring consistency in financial reporting[155]. - The company follows specific accounting policies for revenue recognition and other transactions, tailored to its operational characteristics[151]. Investment and Capital Management - The company plans to continue increasing investment in environmental protection and expand its pesticide product offerings in the future[34]. - The company plans to leverage its technological and environmental advantages to increase market share post-restructuring in the pesticide industry[46]. - The company aims to pursue mergers and acquisitions that align with its strategic development and create synergies[46]. - The company has completed upgrades and technical improvements to enhance safety and environmental standards[45].

Financial Performance - The company's operating revenue for 2018 was CNY 1,316,552,081.21, representing a 4.55% increase compared to CNY 1,259,225,624.46 in 2017[21]. - Net profit attributable to shareholders for 2018 was CNY 138,785,929.78, a significant increase of 29.70% from CNY 107,006,208.75 in 2017[21]. - The basic earnings per share for 2018 was CNY 2.14, reflecting a growth of 20.22% compared to CNY 1.78 in 2017[22]. - The company's total assets increased by 32.24% to CNY 1,491,259,917.31 at the end of 2018, up from CNY 1,127,672,719.09 in 2017[21]. - The net asset attributable to shareholders reached CNY 1,108,683,202.89, marking a 102.98% increase from CNY 546,212,747.13 in 2017[21]. - The cash flow from operating activities for 2018 was CNY 152,900,739.47, which is a decrease of 22.97% compared to CNY 198,488,219.49 in 2017[21]. - The company reported a diluted earnings per share of CNY 2.14 for 2018, consistent with the basic earnings per share[22]. - The weighted average return on equity for 2018 was 19.59%, down by 2.05 percentage points from 21.64% in 2017[22]. Dividend Policy - The company plans to distribute a cash dividend of RMB 5.25 per 10 shares, totaling RMB 42 million for the year 2018[5]. - The company emphasizes a stable and continuous profit distribution policy, prioritizing cash dividends while considering sustainable development[129]. - Cash dividends are contingent upon positive net profits, sufficient cash flow, and the absence of major investment plans exceeding 30% of total assets[133]. - The company will distribute cash dividends at least 10% of the distributable profits for the year, with a minimum of 30% over any three consecutive years[136]. - In mature stages without major capital expenditures, cash dividends should constitute at least 80% of the profit distribution; if there are major expenditures, this minimum is 40%[136]. - For growth stages with significant capital expenditures, cash dividends should be at least 20% of the profit distribution[136]. - The company reported that there are no existing or potential competitive businesses operated by the actual controllers that could conflict with the company's main business[145]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[7]. - The company has detailed its potential risks and corresponding measures in the report[7]. - The company faces risks related to environmental regulations and safety production, which may increase operational costs if compliance is not met[120]. - The company is exposed to raw material price volatility risks, particularly for key inputs like dichloronicotinic acid and ethyl chloride, which could impact production costs[121]. - The company faces significant market competition risks due to a large number of small pesticide manufacturers and increasing entry of international giants, which may lead to price volatility[123]. - Currency exchange rate fluctuations pose risks to the company's export products, prompting the use of financial tools to mitigate these risks[124]. - Rising human resource costs and talent retention challenges are critical risks, with the company implementing measures to stabilize its workforce and attract high-quality talent[125]. Environmental Initiatives - The company invested 145 million yuan in environmental protection during the reporting period, enhancing its overall environmental production level and achieving efficient pollutant treatment and compliance discharge[38]. - The company has implemented a comprehensive waste management system, ensuring that all hazardous waste is processed by qualified disposal units without external discharge[183]. - The company has upgraded its air pollution control facilities, including the installation of a new 20,000 m³/h RTO incinerator, enhancing the efficiency of VOCs treatment[182]. - The company received the "2018 Environmental Management First Prize" from the Dafeng Port Petrochemical New Materials Industrial Park for its compliance with environmental regulations[184]. - The company has maintained compliance with environmental protection laws, with no administrative penalties or pollution incidents reported during the reporting period[184]. Research and Development - The company has built a robust research and development framework, establishing several technology centers and achieving multiple authorized invention patents, including key new products recognized at the national level[39]. - The company’s R&D expenses increased by 23.96% to 41.5 million RMB, focusing on product innovation and process optimization[54]. - The company has obtained a total of 11 invention patents by the end of the reporting period, reflecting its commitment to research and development[85]. - The company is developing new products including new fungicides, herbicides, and insecticides, adhering to a development philosophy of high efficiency, low toxicity, and environmental protection[86]. Market Strategy - The company has established stable sales channels in both domestic and international markets, enhancing its revenue and profit stability while improving risk resistance[43]. - The company expanded its international market presence, with exports accounting for 33% of total sales[49]. - The company aims to enhance its marketing service level and establish long-term strategic partnerships with international agrochemical companies to increase its market share and competitiveness[110]. - The company has implemented a dual sales strategy combining direct sales and distribution, optimizing resource allocation and reducing financial pressure associated with building a marketing network[35]. Financial Management - The company has entrusted a total of RMB 260 million in financial products sourced from raised funds, with an outstanding balance of RMB 230 million[155]. - The company has engaged in various financial management activities, including a principal-protected financial product with a projected annualized return of approximately 4.10%[158]. - The company has invested in projects with expected annual production capacities of 1,500 tons of nitro-sulfonyl ketone and 800 tons of quinclorac, among others, which are crucial for its growth strategy[126]. - The company has a total of 50,000.00 RMB in a guaranteed financial product with an interest rate of approximately 3.00%, yielding an interest of 16.1 RMB[162]. Social Responsibility - In 2018, the company donated a total of 1.26 million RMB to the elderly care center in Caomiao Town and 50,000 RMB for poverty alleviation in Caomiao[168]. - The company provided 400,000 RMB in financial aid to two university students and donated 73,000 RMB to the Jiangsu Provincial Children's Welfare Foundation[168]. - The company engaged in social welfare activities, contributing 23.26 million RMB towards various initiatives, including 10 million RMB for East-West poverty alleviation cooperation[172]. - The company has committed to ongoing poverty alleviation efforts, planning to make regular donations based on its operational development[173].